MetLife Investment Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.55M | Sell |
225,996
-7,746
| -3% | -$87.3K | 0.02% | 880 |
|
|
2025
Q1 | $2.36M | Sell |
233,742
-8,295
| -3% | -$83.7K | 0.01% | 964 |
|
|
2024
Q4 | $2.86M | Buy |
242,037
+16,717
| +7% | +$198K | 0.02% | 865 |
|
|
2024
Q3 | $2.6M | Buy |
225,320
+46,879
| +26% | +$541K | 0.01% | 889 |
|
|
2024
Q2 | $1.89M | Buy |
178,441
+108,259
| +154% | +$1.14M | 0.01% | 999 |
|
|
2024
Q1 | $740K | Buy |
70,182
+49,399
| +238% | +$521K | 0.01% | 1465 |
|
|
2023
Q4 | $233K | Buy |
+20,783
| New | +$233K | ﹤0.01% | 2155 |
|
|
2023
Q3 | – | Sell |
-14,438
| Closed | -$146K | – | 2964 |
|
|
2023
Q2 | $146K | Buy |
+14,438
| New | +$146K | ﹤0.01% | 2459 |
|